Skip to main content
Scott Rodig, MD, Pathology, Boston, MA, Brigham and Women's Hospital

ScottJRodigMD

Pathology Boston, MA

Hematopathology, Anatomic Pathology, Clinical Pathology

Associate Professor, Pathology-Brigham & Women's Hospital, Harvard Medical School

Are you Dr. Rodig?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 32 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    75 Francis St
    Brigham & Women's Hospital, Dept. Of Pathology, Amory 3
    Boston, MA 02115
    Phone(617) 732-7510
  • Is this information wrong?

Summary

  • Dr. Scott Rodig, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Brigham and Women's Hospital and is an Associate Professor at Harvard Medical School.

Education & Training

  • Brigham and Womens Hospital
    Brigham and Womens HospitalResidency, Anatomic and Clinical Pathology, 1998 - 2002
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1998

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2002 - 2023
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Pathology Recertification
  • American Board of Pathology Hematology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Study Finds Melanoma Biomarkers Predicting Checkpoint Blocker Response
    Study Finds Melanoma Biomarkers Predicting Checkpoint Blocker ResponseJuly 18th, 2018
  • Research Update: Biomarkers as Predictors of Immunotherapy Response in Melanoma
    Research Update: Biomarkers as Predictors of Immunotherapy Response in MelanomaSeptember 13th, 2018
  • Immunotherapy Achieves Breakthrough Result in Patients with Hodgkin Lymphoma
    Immunotherapy Achieves Breakthrough Result in Patients with Hodgkin LymphomaDecember 7th, 2014
  • Join now to see all

Hospital Affiliations